par C829 (Diltiazem Hydrochloride Extended-Release 120 mg)

Pill with imprint par C829 is Gray, Capsule-shape and has been identified as Diltiazem Hydrochloride Extended-Release 120 mg. It is supplied by Par Pharmaceutical, Inc..

Diltiazem is used in the treatment of atrial fibrillation; atrial flutter; heart failure; angina pectoris prophylaxis; high blood pressure and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 120 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for par C829

Diltiazem Hydrochloride Extended-Release

Imprint

par C829

Strength

120 mg

Color

Gray

Size

18.00 mm

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Calcium channel blocking agents, Group IV antiarrhythmics

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Par Pharmaceutical, Inc.

Inactive Ingredients

ammonio methacrylate copolymer type A, ammonio methacrylate copolymer type B, ammonia, gelatin, hydroxypropyl cellulose (type l), propylene glycol, shellac, sodium lauryl sulfate, sucrose, magnesium silicate, titanium dioxide, triethyl citrate, ferrosoferric oxide, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code	Labeler / Repackager
10370-0829	Anchen Pharmaceuticals, Inc.
63739-0283	McKesson Packaging Services
63739-0283	McKesson Packaging Services
42291-0184	AvKare, Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer